• The Avicenna Alliance discussed upcoming activities

    The Avicenna Alliance board was convened by Secretary General Thierry Marchal on 23 March where board members around the world discussed the activities of the Alliance.

    FIND OUT MORE

  • Avicenna Alliance founding Sec Gen leaves legacy of policy success

    As the Avicenna Alliance enters its 3rd year of operation in 2018, it brings with it a change in management and a huge upscaling of activities.

    FIND OUT MORE

  • Avicenna Alliance continues to grow by welcoming Cipla among its members

    The latest company to join Avicenna Alliance is the pharmaceutical company Cipla.

    FIND OUT MORE

Avicenna Alliance proclaims victory in EMA Regulation

The Avicenna Alliance, can claim a major victory in the revised EMA Regulation with the introduction of new text supporting modelling and...

find out more ›

EMA Regulation amendments call for framework for in silico

Amendments calling for the creation of a framework for in silico medicine have been tabled by MEP Martin Häusling (Greens/EFA, Germany) to...

find out more ›

US Legislature says FDA should use in silico methods

In an unprecedented victory for the in silico community in the US Congress has put forward a bill that “urges FDA to engage with device and drug...

find out more ›